Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
04/2002
04/02/2002CA2097928C Uracil derivatives
03/2002
03/28/2002WO2002024693A1 A process for producing 3,4-dihydro naphthyridinone analogs
03/28/2002WO2002024687A1 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinolinone derivatives
03/28/2002WO2002024686A2 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives
03/28/2002WO2002024683A1 Farnesyl transferase inhibiting 6-[(substituted phenyl)methyl]-quinoline and quinazoline derivatives
03/28/2002WO2002024682A1 Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors
03/28/2002WO2002024679A1 PYRIDINE DERIVATIVES WITH IKB-KINASE (IKK-β) INHIBITING ACTIVITY
03/28/2002WO2002024667A1 4-amino-quinazolines
03/28/2002WO2002024666A2 4-amino-quinazolines
03/28/2002WO2002024665A1 Arylalkane-sulfonamides having endothelin-antagonist activity
03/28/2002WO2002024655A1 Isoquinolinone potassium channel inhibitors
03/28/2002WO2002024651A1 A process for producing 2-amino-4,6-disubstituted nicotinic acid ester analogs
03/28/2002WO2002024650A2 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
03/28/2002WO2002024649A1 Substituted amino-aza-cycloalkanes useful against malaria
03/28/2002WO2002024646A1 Delta1-pyrrolines used as pesticides
03/28/2002WO2002009651A3 Fatty acid synthase inhibitors
03/28/2002WO2001072735A3 Benzopyranes useful as tnf alpha inhibitors
03/28/2002WO2001064676A3 INHIBITORS OF p38-α KINASE
03/28/2002US20020037915 4-(4-(1- phenyl-5-propylpyrazol4-yl)(1,3-thiazol-2-yl))-5-methylthiothiophene-2 -carboxamidine, for example; complement inhibitors; treating tissue damage, inflammation, or autoimmune diseases
03/28/2002US20020037909 Enamine derivatives
03/28/2002US20020037907 Substituted 2- (S) -hydroxy-3- (piperidin-4-yl-methylamino) -propyl ethers and substituted 2-aryl-2- (R) - hydroxy-1- (piperidin-4-yl-methyl) -ethylamine beta-3 adrenergic receptor agonists
03/28/2002US20020037900 Hydroxamic acid derivatives
03/28/2002US20020037886 Muscarinic agonists
03/28/2002US20020037856 Novel compounds possessing antibacterial, antifungal or antitumor activity
03/28/2002DE10038436A1 New 5-acceptor-functionalized 2-diarylamino thiophene or thiazole derivatives, especially useful for making organic light-emitting diodes
03/28/2002CA2423315A1 Substituted amino-aza-cycloalkanes useful against malaria
03/28/2002CA2422923A1 Pyridine derivatives with ikb-kinase (ikk-.beta.) inhibiting activity
03/28/2002CA2422560A1 4-amino-quinazolines
03/28/2002CA2422488A1 4-amino-quinazolines
03/27/2002EP1191612A2 Luminescence device, display apparatus and metal coordination compound
03/27/2002EP1189905A1 Substituted heterocycle fused gamma-carbolines
03/27/2002EP1189904A1 Substituted heterocycle fused gamma-carbolines
03/27/2002EP1189893A2 Substituted 2-aryl-1,2,4-triazine-3,5-di(thi)one
03/27/2002EP1189890A1 Dihydrobenzodiazepins and their use for treating dyslipidemia
03/27/2002EP1189888A1 HETEROSUBSTITUTED PYRIDINE DERIVATIVES AS $i(PDE 4) INHIBITORS
03/27/2002EP1189883A2 Substituted pyrrolidines as cell adhesion inhibitors
03/27/2002EP1189881A1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors
03/27/2002EP1189609A1 Cxcr-4 receptor antagonists - thrombopoietin mimetics
03/27/2002CN1342157A Substituted pyrazoles ASP38 kinase inhibitors
03/27/2002CN1342149A Prostaglandin endoperoxide H synthase biosynthesis inhibitors
03/27/2002CN1342145A Fused-ring compounds and use thereof as drugs
03/27/2002CN1341596A Method for synthesizing benz [b] thiophenes compound
03/27/2002CN1341594A Substituted pyrrolidone, thiazolidone or oxazolidone as herbicide
03/27/2002CN1081635C Substituted pyrrolidine-3-Yl-alkyl-piperidines
03/27/2002CA2321348A1 Aromatic derivatives with hiv integrase inhibitory properties
03/26/2002US6362337 Substituted phenyluracils
03/26/2002US6362336 Administering a quinazoline derivative to a warm-blooded animal for producing an antiangiogenic and/or vascular permeability reducing effect
03/26/2002US6362230 Alzheimer's disease
03/26/2002US6362216 Antiinflammatory agents
03/26/2002US6362201 3-cyclopropyl and 3-cyclobutyl pyrrolidine modulators of chemokine receptor activity
03/26/2002US6362196 Method to treat pain utilizing benzimidazole NMDA/NR2B antagonists
03/26/2002US6362177 Cyclic amine derivatives and their use as drugs
03/26/2002CA2137953C Benzenesulfonamide derivative and process for preparing thereof
03/21/2002WO2002022694A1 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
03/21/2002WO2002022608A1 Pyrazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022607A1 Pyrazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022606A1 Pyrazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022605A1 Pyrazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022604A1 Pyrazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022603A1 Pyrazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022602A2 Triazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022601A1 Pyrazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022600A2 Chemokine receptor binding heterocyclic compounds
03/21/2002WO2002022598A1 Quinolinone derivatives as tyrosine kinase inhibitors
03/21/2002WO2002022595A1 N-substituted benzothiophenesulfonamide derivatives
03/21/2002WO2002022592A2 Substituted urea neuropeptide y y5 receptor antagonists
03/21/2002WO2002022588A1 Novel pyrimidine derivative and novel pyridine derivative
03/21/2002WO2002022579A2 Antipsychotic sulfonamide-heterocycles, and methods of use thereof
03/21/2002WO2002022577A2 Hydroxamate derivatives useful as deacetylase inhibitors
03/21/2002WO2002022576A2 3-substituted indole carbohydrazides useful as cell proliferation and angiogenesis inhibitors
03/21/2002WO2002022556A1 Novel amide derivatives and medicinal use thereof ugs
03/21/2002WO2002008186A3 Cyclopentanoindoles, compositions containing such compounds and methods of treatment
03/21/2002WO2002006255A3 Hydroxy-(piperidin-4-yl-methylamino)-alkyl beta-3 adrenergic receptor antagonists
03/21/2002WO2001095858A3 Piperazinedione compounds
03/21/2002WO2001087846A3 Tricyclic pyrazole derivatives as protein kinase inhibitors
03/21/2002US20020035272 Furans, benzofurans, and thiophenes useful in the treatment of insulin resistance and hyperglycemia
03/21/2002US20020035127 Phenylalanine derivatives
03/21/2002US20020035103 For diseases or conditions caused by or exacerbated by histamine-3 receptor activity
03/21/2002US20020035102 Azetidine derivatives, their preparation and medicaments containing them
03/21/2002US20020035094 Substituted pyridine compounds and methods of use
03/21/2002US20020034658 Organic electroluminescent device comprising dipyridylthiophene derivative
03/21/2002CA2742411A1 Pyridazinone and triazinone compounds and use thereof as pharmaceutical preparations
03/21/2002CA2422013A1 Substituted urea neuropeptide y y5 receptor antagonists
03/21/2002CA2421054A1 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
03/21/2002CA2419224A1 Chemokine receptor binding heterocyclic compounds
03/21/2002CA2357467A1 Methods for treating osteoarthritis using an estrogen agonist/antagonist
03/20/2002EP1188755A1 Acylhydrazine derivatives, process for preparing the same and use thereof
03/20/2002EP1188747A1 Phenoxypropylamine compounds
03/20/2002EP1188376A1 Triketone derivatives and herbicides for lowland fields
03/20/2002EP1187826A1 Heterocyclic derivatives useful as anticancer agents
03/20/2002EP1187821A1 Benzofuranylsulfonates
03/20/2002EP1187816A1 5-cyano-2-aminopyrimidine derivatives
03/20/2002EP1187813A1 Azolylbenzamides and analogues and their use for treating osteoporosis
03/20/2002EP1187811A1 Inhibitors of metalloproteinases
03/20/2002EP1187810A2 Heterocyclic analgesic compounds and their use
03/20/2002EP1143796A4 Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-beta-cyclodextrin or 2-hydroxypropyl-beta-cyclodextrin and method
03/20/2002EP0944587B1 Metalloproteinase inhibitors
03/20/2002CN1341102A Dopamine D1 receptor agonist compounds
03/19/2002US6359154 Exceptional utility as antitumor agents; bioavailability and nontoxic; oral administration; e.g., 10-hydroxy-10-deacetyl baccatin iii; anticarcinogenic agents
03/19/2002US6359151 Use as pesticides.